Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Alexander Fleming

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Diabetes Science and Technology|October 27, 2011
Counterpoint--the end point: less is moreG Alexander Fleming
Journal of Diabetes Science and Technology|February 11, 2010
Glutamic Acid decarboxylase therapy for recent-onset type 1 diabetes: are we at the end or the beginning of finding a cure?G Alexander Fleming, David C Klonoff
Diabetes Care|April 20, 2026
The Importance of C-Peptide for Developing T1D Disease-Modifying TherapiesG Alexander Fleming, Chantal Mathieu, Jay S Skyler
Metabolism: Clinical and Experimental|January 17, 2016
Metformin-associated lactic acidosis: Current perspectives on causes and riskRalph DeFronzo, G Alexander Fleming, Kim Chen, et al.
Metabolism: Clinical and Experimental|June 18, 2016
Corrigendum to "Metformin-associated lactic acidosis: Current perspectives on causes and risk" [Metabolism 65 (2016) 20-29]Ralph DeFronzo, G Alexander Fleming, Kim Chen, et al.
Diabetes/Metabolism Research and Reviews|January 6, 2017
Hypoglycemia evaluation and reporting in diabetes: Importance for the development of new therapiesDavid C Klonoff, G Alexander Fleming, Douglas B Muchmore, et al.
Diabetes Care|September 26, 2015
Alternate approaches for pediatric type 1 diabetes drug development and potential regulatory approval: a perspectiveJ Rick Turner, Kelly L Close, G Alexander Fleming, et al.
Diabetes Care|October 27, 2017
Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working GroupJohn R Petrie, Anne L Peters, Richard M Bergenstal, et al.
Diabetes Care|March 18, 2015
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working GroupLutz Heinemann, G Alexander Fleming, John R Petrie, et al.
Diabetologia|March 19, 2015
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working GroupLutz Heinemann, G Alexander Fleming, John R Petrie, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Diabetes Science and Technology|October 27, 2011
Counterpoint--the end point: less is moreG Alexander Fleming
Journal of Diabetes Science and Technology|February 11, 2010
Glutamic Acid decarboxylase therapy for recent-onset type 1 diabetes: are we at the end or the beginning of finding a cure?G Alexander Fleming, David C Klonoff
Diabetes Care|April 20, 2026
The Importance of C-Peptide for Developing T1D Disease-Modifying TherapiesG Alexander Fleming, Chantal Mathieu, Jay S Skyler
Metabolism: Clinical and Experimental|January 17, 2016
Metformin-associated lactic acidosis: Current perspectives on causes and riskRalph DeFronzo, G Alexander Fleming, Kim Chen, et al.
Metabolism: Clinical and Experimental|June 18, 2016
Corrigendum to "Metformin-associated lactic acidosis: Current perspectives on causes and risk" [Metabolism 65 (2016) 20-29]Ralph DeFronzo, G Alexander Fleming, Kim Chen, et al.
Diabetes/Metabolism Research and Reviews|January 6, 2017
Hypoglycemia evaluation and reporting in diabetes: Importance for the development of new therapiesDavid C Klonoff, G Alexander Fleming, Douglas B Muchmore, et al.
Diabetes Care|September 26, 2015
Alternate approaches for pediatric type 1 diabetes drug development and potential regulatory approval: a perspectiveJ Rick Turner, Kelly L Close, G Alexander Fleming, et al.
Diabetes Care|October 27, 2017
Improving the Clinical Value and Utility of CGM Systems: Issues and Recommendations: A Joint Statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working GroupJohn R Petrie, Anne L Peters, Richard M Bergenstal, et al.
Diabetes Care|March 18, 2015
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting, and research needs: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working GroupLutz Heinemann, G Alexander Fleming, John R Petrie, et al.
Diabetologia|March 19, 2015
Insulin pump risks and benefits: a clinical appraisal of pump safety standards, adverse event reporting and research needs. A joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working GroupLutz Heinemann, G Alexander Fleming, John R Petrie, et al.
Pageof 4